Medical Oncology Hematology Consultants

Recent papers from Medical Oncology Hematology Consultants

1. Medical Management of Non–Small Cell Lung Cancer Brain Metastases in the Modern EraThe Cancer Journal · 2026
2. Cardio-oncology in multidisciplinary synergy: addressing the rising burden of cancer therapy-related cardiovascular toxicity (CTR-CVT) in advancing oncology practicesOncology Reviews · 2026
3. An AI-powered, human-in-the-loop, real-time registry platform to enable clinical trials, pragmatic studies, and prospective external control arms (ProECA) at scale in US community practices.Journal of Clinical Oncology · 2026
4. Exercising electrocardiograms from Thoroughbred racehorses with exercise associated sudden deathEquine Veterinary Journal · 2026
5. Artificial Intelligence and Burnout among Professionals: The Moderating Role of Cognitive Efficacy2026
6. Real-world ARPI utilization patterns and outcomes in metastatic castration-sensitive prostate cancer.Journal of Clinical Oncology · 2026
7. Real-world time to next treatment in metastatic urothelial cancer patients: Enfortumab vedotin and pembrolizumab vs chemotherapy as first-line treatment.Journal of Clinical Oncology · 2026
8. Precision diagnostics in prostate cancer treatment (PREDICT): A phase 2 multi-arm biomarker-based study (Alliance A032102).Journal of Clinical Oncology · 2026
9. Updated efficacy results from the phase 1 study of gotistobart (BNT316/ONC-392) in combination with lutetium Lu 177 vipivotide tetraxetan (Lu 177) in patients with metastatic castration-resistant prostate cancer (mCRPC).Journal of Clinical Oncology · 2026
10. Clinical outcomes in the real-world utilization of 177Lu-PSMA 617 in metastatic castrate-resistant prostate cancer.Journal of Clinical Oncology · 2026
11. A Droplet Microfluidic Approach to Investigate How Fibroblasts Alter Collagen I Spatial Distribution and Endocrine Response in ER ⁺ Breast CancerACS Biomaterials Science & Engineering · 2025
12. Efficacy and safety of one-time autologous tumor-infiltrating lymphocyte cell therapy in patients with recurrent and/or metastatic head and neck squamous cell carcinomaJournal for ImmunoTherapy of Cancer · 2025
13. CRESTONE: A Phase II Study of the Efficacy and Safety of the HER3 Monoclonal Antibody, Seribantumab, in Solid Tumors With Neuregulin-1 ( NRG1 ) FusionsJCO Precision Oncology · 2025
14. Oncology Medical Homes: ASCO-Community Oncology Alliance StandardsJCO Oncology Practice · 2025
15. Comparison of MRI, [18F]FDG-PET/CT, and [18F]FDG-PET/MRI for Initial Staging of Multiple MyelomaClinical Nuclear Medicine · 2025
16. Zanubrutinib is well tolerated and effective in patients with CLL/SLL intolerant of ibrutinib/acalabrutinib: updated resultsBlood Advances · 2025
17. Navigating Challenges in Palliative Care: A Survey on ASCO Guideline Adherence Among Health Care Providers in Low- and Middle-Income CountriesJCO Global Oncology · 2025
18. Cancer in rural America: Improving access to clinical trials and quality of oncologic careCA A Cancer Journal for Clinicians · 2025
19. A Case of Atypical Meig’s Syndrome Presenting With Pleural and Pericardial EffusionCureus · 2025
20. Electrocardiograms from different types of exercise in Eventing horses with and without cardiac signsEquine Veterinary Journal · 2024